Hikma Seeks Rehearing In Vascepa Skinny-Label Case

 
• By Dave Wallace
  
US Court of Appeals for the Federal Circuit sign
Hikma asked for an en banc panel rehearing. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet